ROYAL BANK OF CANADA - SKYSTAR BIO-PHARMA CO ownership

SKYSTAR BIO-PHARMA CO's ticker is SKBI and the CUSIP is 830884300. A total of 10 filers reported holding SKYSTAR BIO-PHARMA CO in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SKYSTAR BIO-PHARMA CO
ValueSharesWeighting
Q2 2015$81,000
-33.1%
30,573
-1.2%
0.00%
Q1 2015$121,000
-9.7%
30,934
-2.9%
0.00%
Q4 2014$134,000
-10.7%
31,852
-10.8%
0.00%
Q3 2014$150,000
-42.1%
35,722
+1.1%
0.00%
Q2 2014$259,000
+11.6%
35,323
-0.2%
0.00%
Q1 2014$232,000
+85.6%
35,391
-0.2%
0.00%
Q4 2013$125,000
-50.8%
35,472
-18.7%
0.00%
Q3 2013$254,00043,6410.00%
Other shareholders
SKYSTAR BIO-PHARMA CO shareholders Q3 2015
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 147,926$141,0000.01%
Tower Research Capital LLC (TRC) 181$00.00%
HighTower Advisors, LLC 22,845$22,0000.00%
MORGAN STANLEY 11,593$11,0000.00%
BlackRock Institutional Trust Company, N.A. 175,708$167,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 15,900$15,0000.00%
Walleye Trading LLC 200$00.00%
Citadel Advisors 18,296$17,0000.00%
Renaissance Technologies 52,300$50,0000.00%
UBS Group AG 3,304$3,0000.00%
View complete list of SKYSTAR BIO-PHARMA CO shareholders